Price Watch

PriceWatch: U.S. Cost of Insulin Nearly Triples from 2012 to 2016

PriceWatch: U.S. Cost of Insulin Nearly Triples from 2012 to 2016

Reuters reported that the cost of insulin for treating type 1 diabetes in the U.S. has nearly doubled over a five-period according to a new analysis by nonprofit Health Care Cost Institute (HCCI). Reuters noted that the increases are putting some patients at risk. The...

Price Watch: The RESOLVE (PCYC-1137) Phase 3 Updates and IMBRUVICA

Price Watch: The RESOLVE (PCYC-1137) Phase 3 Updates and IMBRUVICA

AbbVie updated markets via PR NewsWire on its RESOLVE (PCYC-1137) trial which evaluated ibrutinib in combination with chemotherapy agents nab-paclitaxel and gemcitabine versus placebo in combination with the chemotherapy agents. The commercial sponsor reports that the...

PriceWatch: GoodRx Lists 20 Most Expensive Drugs for 2018

PriceWatch: GoodRx Lists 20 Most Expensive Drugs for 2018

Tori Marsh writing for GoodRX provides an important list of the 20 top most expensive drugs in 2018. We recommend you select the link to the Ms. Marsh's story to learn more. For summary, TrialSite News provides the top 11 most expensive medications for 2018: Drug List...

Diabetes Drug Costs: More Patients and Higher Costs

Diabetes Drug Costs: More Patients and Higher Costs

TrialSite News seeks to bring transparency to clinical trials and the overall drug development industry. With a focus on research sites, we also include investigator profiles, site watch, trial watch and price watch feature news tabs. Within the world of price watch...

subscribe

CNS Summit
subscribe

Pin It on Pinterest